Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 |
filingDate |
2007-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51f9d285c8d364060d48a6f035f977fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9fd86e8bc08a4cb036fb232d88d59cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0ca8628f6045f4edb3d7c57f037d7dd |
publicationDate |
2007-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007254861-A1 |
titleOfInvention |
Methods for the prevention and/or treatment of peripheral arterial disease |
abstract |
A method for the prevention and/or treatment of peripheral arterial disease by compound (I) or its pharmaceutically salts are provided. The compound (I) or its pharmaceutically salts have inhibitory activity against heterotrimeric G protein Gq/11. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013131161-A1 |
priorityDate |
2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |